A Double-blind, Placebo-controlled Clinical Trial of Fluvoxamine for Symptomatic Individuals With COVID-19 Infection

April 13, 2020 | Community/Outpatient Based | 

300mg per day (3 capsules per day) as tolerated for approximately 15 days

Be the First to Know

Sign up to get updates when we add new off-label treatments, articles, videos, and clinical trials!